PET/MR bests PET/CT in identifying prostate cancer recurrence

06/21/2013 | Medscape (free registration)

PET/MR imaging with 11C-choline for restaging of prostate cancer was well-tolerated and able to identify more small local recurrences than PET/CT, according to a study presented at the SNMMI Annual Meeting. The radiation dose exposure with PET/MR imaging is about 80% lower than with PET/CT, researchers said, suggesting the approach may be particularly beneficial for patients who need a number of tests.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX